Synapse Biomedical is focused on the development and commercialization of minimally invasive neurostimulation technologies for the diagnosis and treatment of neurodegenerative impairments.

Compared to traditional surgeries and devices, the company’s minimally invasive surgical interventions and respiratory assist procedures reduce risks to both patients and surgeons and are performed at a substantially lower cost.

Industry Sector
Biomedical & Health Tech

Founded
2002

JumpStart Investment
Evergreen Fund